| Market Cap | ₹1,09,200Cr |
| ROE | 16.53% |
| P/E Ratio(TTM) | 24.09 |
| EPS(TTM) | 56.12 |
| P/B Ratio | 3.32 |
| Dividend Yield | 1.18% |
| Industry P/E | 32.50 |
| Book Value | 407.52 |
| Debt to Equity | 0.01 |
| Face Value | 2 |
| Managing Director | Mr Umang Vohra |
| Founded | 1935 |
| NSE Symbol | CIPLA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 38.39 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 19.57 | ||
| Lupin | NA (0.00%) | 22.63 | ||
| Mankind Pharma | NA (0.00%) | 51.40 |